Serge-Marchand-Kinesiologist-Ps. Ed., PhD

Serge Marchand



Pain science

Quebec, Canada
/ English, French
Serge Marchand was recently named Scientific Director at Lucine (CSO) a startup in digital therapy (Digital Therapeutics – DTx) in Bordeaux, France. He is a researcher at the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (CRCHUS) where he held the position of Scientific Director of the CRCHUS from 2008 to 2013. He is the author of several articles, books and book chapters on pain. His research focuses on the neurophysiological mechanisms responsible for the development and persistence of chronic pain.


Serge Marchand is a professor at the Faculty of Medicine and Health Sciences of the University of Sherbrooke and Scientific Director of Lucine, a Bordeaux-based digital therapy company. Doctor in neurological sciences from the University of Montreal and a postdoctoral fellowship from the University of California at San Francisco (UCSF), he served as Scientific Director of CRCHUS from 2008 to 2013. He was Scientific Director of the Fonds de recherche en santé du Québec from 2017 to 2019 and Vice President of Scientific Affairs at Génome Québec from 2019 to 2020. He is the author of several articles, books and book chapters on pain. His research focuses on the neurophysiological mechanisms responsible for the development, persistence and response to treatments of chronic pain.

Career highlights :

  • Discovery of the importance of endogenous pain modulation mechanisms in the development, persistence and treatment of pain

University studies

  • Bachelor of Applied Science, Psychoeducation (Université du Québec en Abitibi-Témiscamingue, 1983)
  • Master of Science, Kinesthesiology (Université du Québec à Trois-Rivières, 1986)
  • Doctor of Philosophy, Neuroscience (Université de Montréal (1992)
  • Post-Doctorat, Pain Neuroanatomy (University of California, San Francisco, 1994)

Teaching experiences

  • Professor at University of Sherbrooke
  • Regular participation in several conferences
  • Continuing Medical Education
  1. Harvey MP, Dubois MC, Chalaye P, Sansoucy Y, Marchand S. Sex-Related Effects of Adrenergic Drugs on Conditioned Pain Modulation: A Randomized Controlled Cross-Over Double-Blind Trial. Pain Res Manag. 2022 Oct 26;2022:2757101. doi: 10.1155/2022/2757101. PMID: 36339068; PMCID: PMC9629924. Open access article: Click here!
  2. Sean M, Coulombe-Lévêque A, Vincenot M, Martel M, Gendron L, Marchand S, Léonard G. Transcutaneous electrical nerve stimulation (TENS): towards the development of a clinic-friendly method for the evaluation of excitatory and inhibitory pain mechanisms. Can J Pain. 2021 Mar 23;5(1):56-65. doi: 10.1080/24740527.2020.1862624. PMID: 34189390; PMCID: PMC8210867. Open access article: Click here!
  3. Edwards RR, Schreiber KL, Dworkin RH, Turk DC, Baron R, Freeman R, Jensen TS, Latremoliere A, Markman JD, Rice ASC, Rowbotham M, Staud R, Tate S, Woolf CJ, Andrews NA, Carr DB, Colloca L, Cosma-Roman D, Cowan P, Diatchenko L, Farrar J, Gewandter JS, Gilron I, Kerns RD, Marchand S, Niebler G, Patel KV, Simon LS, Tockarshewsky T, Vanhove GF, Vardeh D, Walco GA, Wasan AD, Wesselmann U. Optimizing and Accelerating the Development of Precision Pain Treatments for Chronic Pain: IMMPACT Review and Recommendations. J Pain. 2023 Feb;24(2):204-225. doi: 10.1016/j.jpain.2022.08.010. Epub 2022 Oct 2. PMID: 36198371. Open access article: Click here!


For more publications: Click here!



Courses & Webinars

Show more

3.25 hrs

Related Courses

Show more


Global Approach to Pain Management - Level 3

Bahram Jam, Ebonie Rio, Emmanuelle Rivest-Gadbois, Stéphanie Thibault-Gagnon
33 hrs
1.25 hr

Other Instructors

Florian Forelli

Physiotherapist Ph.D, PT, ATC.

Isabelle Demers

Physiotherapist Ph.D., PT
Quebec, Canada

Julie Marier

Physiotherapist PT
Quebec, Canada

Marie-France Blais

Nurse, IBCLC lactation consultant IBCLC
Paediatrics, Women's Health

Free webinar on June 13, 2024

Sensory-Motor Dysregulation: An Exciting Target for Persistent Pain